|
|
|
Corporate Profile: Viventia Biotech
| Summary: |
|
Viventia Biotech is involved in teh discovery,
development, and commercialization of monoclonal
antibodies for the treatment of cancer.
|
| Address (HQ): |
147 Hamelin Street
Winnipeg, MB R3T 3Z1
Canada |
| Phone #'s (HQ): |
| Main |
(204) 478-1023 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax #'s (HQ): |
| Main |
(204) 452-7721 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| email: |
| Main |
not known |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Financial
information: |
| not
known |
| Internet
job postings: |
| not
known |
| Number
of employees: |
| not
known |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
